New buprenorphine treatment option approved for opioid use disorder

被引：0
|
作者：
不详
机构：
来源：
NURSE PRACTITIONER | 2023年 / 48卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R47 [护理学];
学科分类号：
1011 ;
摘要：
引用
下载
收藏
页码：48 / 48
页数：1
相关论文
共 50 条
  • [41] The Pharmacology of Buprenorphine Microinduction for Opioid Use Disorder
    De Aquino, Joao P.
    Parida, Suprit
    Sofuoglu, Mehmet
    CLINICAL DRUG INVESTIGATION, 2021, 41 (05) : 425 - 436
  • [42] Quality of buprenorphine care for opioid use disorder
    Anderson, Kelly E.
    Eckstein, Julia
    Chaisson, Christine E.
    Scholle, Sarah H.
    Niles, Lauren
    Dy, Sydney M.
    Saloner, Brendan
    Alexander, G. Caleb
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 199 - 200
  • [43] ADOPTION OF ALCOHOL USE DISORDER PHARMACOTHERAPY BY PROVIDERS OF BUPRENORPHINE TREATMENT FOR OPIOID USE DISORDER IN THE UNITED STATES
    Knudsen, H. K.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2018, 42 : 63A - 63A
  • [44] Buprenorphine Use and Spending for Opioid Use Disorder Treatment: Trends From 2003 to 2015
    Roberts, Andrew W.
    Saloner, Brendan
    Dusetzina, Stacie B.
    PSYCHIATRIC SERVICES, 2018, 69 (07) : 832 - 835
  • [45] Barriers to initiate buprenorphine and methadone for opioid use disorder treatment with postdischarge treatment linkage
    Calcaterra, Susan L. L.
    Lockhart, Steven
    Natvig, Crystal
    Mikulich, Susan
    JOURNAL OF HOSPITAL MEDICINE, 2023, 18 (10) : 896 - 907
  • [46] Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder
    Azar, Pouya
    Schneiderman, Hannah
    Barron, Henry
    Wong, James S. H.
    Meyer, Maximilian
    Newman-Azar, Dayyon
    Narimani, Matin
    Ignaszewski, Martha J.
    Mathew, Nickie
    Mullen, Rodney
    Krausz, Reinhard M.
    Maharaj, Anil R.
    ADDICTION SCIENCE & CLINICAL PRACTICE, 2024, 19 (01):
  • [47] Removal of Medicaid Prior Authorization Requirements and Buprenorphine Treatment for Opioid Use Disorder
    Christine, Paul J.
    Larochelle, Marc R.
    Lin, Lewei
    Mcbride, Jonathon
    Tipirneni, Renuka
    JAMA HEALTH FORUM, 2023, 4 (10): : E233549
  • [48] Telemedicine Buprenorphine Initiation and Retention in Opioid Use Disorder Treatment for Medicaid Enrollees
    Hammerslag, Lindsey R.
    Mack, Aimee
    Chandler, Redonna K.
    Fanucchi, Laura C.
    Feaster, Daniel J.
    Larochelle, Marc R.
    Lofwall, Michelle R.
    Nau, Michael
    Villani, Jennifer
    Walsh, Sharon L.
    Westgate, Philip M.
    Slavova, Svetla
    Talbert, Jeffery C.
    JAMA NETWORK OPEN, 2023, 6 (10)
  • [49] National Trends in Buprenorphine Treatment for Opioid Use Disorder From 2007 to 2018
    Schuler, Megan S.
    Saloner, Brendan
    Gordon, Adam J.
    Dick, Andrew W.
    Stein, Bradley D.
    SUBSTANCE ABUSE, 2023, 44 (03) : 154 - 163
  • [50] Recovery capital among people receiving treatment for opioid use disorder with buprenorphine
    Anna Beth Parlier-Ahmad
    Mishka Terplan
    Dace S. Svikis
    Laura Ellis
    Caitlin E. Martin
    Harm Reduction Journal, 18
12345